Financials

News Ideas Technicals

4726 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to MYCENAX BIOTECH INC. operating, investing, and financing activities

4726 free cash flow for Q1 24 is -357.11 M TWD. For 2023, 4726 free cash flow was -411.24 M TWD and operating cash flow was -115.61 M TWD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—